114 related articles for article (PubMed ID: 26711574)
1. Classical and lectin complement pathway activity in polyneuropathy associated with IgM monoclonal gammopathy.
Stork AC; Cats EA; Vlam L; Heezius E; Rooijakkers S; Herpers B; de Jong BA; Rijkers G; van Strijp J; Notermans NC; van den Berg LH; van der Pol WL
J Neuroimmunol; 2016 Jan; 290():76-9. PubMed ID: 26711574
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, specificity and functionality of anti-ganglioside antibodies in neuropathy associated with IgM monoclonal gammopathy.
Stork AC; Jacobs BC; Tio-Gillen AP; Eurelings M; Jansen MD; van den Berg LH; Notermans NC; van der Pol WL
J Neuroimmunol; 2014 Mar; 268(1-2):89-94. PubMed ID: 24529728
[TBL] [Abstract][Full Text] [Related]
3. Serum cytokine patterns in immunoglobulin m monoclonal gammopathy-associated polyneuropathy.
Stork ACJ; Rijkers GT; Vlam L; Cats EA; de Jong BAW; Fritsch-Stork RDE; Veldink JH; van den Berg LH; Notermans NC; van der Pol WL
Muscle Nerve; 2019 Jun; 59(6):694-698. PubMed ID: 30847948
[TBL] [Abstract][Full Text] [Related]
4. Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathy.
Eurelings M; Ang CW; Notermans NC; Van Doorn PA; Jacobs BC; Van den Berg LH
Neurology; 2001 Nov; 57(10):1909-12. PubMed ID: 11723289
[TBL] [Abstract][Full Text] [Related]
5. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
Kuijf ML; Eurelings M; Tio-Gillen AP; van Doorn PA; van den Berg LH; Hooijkaas H; Stork J; Notermans NC; Jacobs BC
Neurology; 2009 Sep; 73(9):688-95. PubMed ID: 19720975
[TBL] [Abstract][Full Text] [Related]
6. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy.
Nobile-Orazio E; Manfredini E; Carpo M; Meucci N; Monaco S; Ferrari S; Bonetti B; Cavaletti G; Gemignani F; Durelli L
Ann Neurol; 1994 Sep; 36(3):416-24. PubMed ID: 8080249
[TBL] [Abstract][Full Text] [Related]
7. Polyneuropathy associated with IgM vs IgG monoclonal gammopathy: comparison between clinical and electrophysiological findings.
Vrethem M; Reiser N; Lauermann C; Svanborg E
Acta Neurol Scand; 2010 Jul; 122(1):52-7. PubMed ID: 20003083
[TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy.
Pascual-Goñi E; Martín-Aguilar L; Lleixà C; Martínez-Martínez L; Simón-Talero MJ; Díaz-Manera J; Cortés-Vicente E; Rojas-García R; Moga E; Juárez C; Illa I; Querol L
Sci Rep; 2019 Apr; 9(1):6155. PubMed ID: 30992531
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of polyneuropathy due to IgM monoclonal gammopathy: a prospective cohort study.
Niermeijer JM; Fischer K; Eurelings M; Franssen H; Wokke JH; Notermans NC
Neurology; 2010 Feb; 74(5):406-12. PubMed ID: 20124206
[TBL] [Abstract][Full Text] [Related]
10. Characterization of neuropathies associated with elevated IgM serum levels.
Goldfarb AR; Sander HW; Brannagan TH; Magda P; Latov N
J Neurol Sci; 2005 Feb; 228(2):155-60. PubMed ID: 15694197
[TBL] [Abstract][Full Text] [Related]
11. Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathy.
Niermeijer JM; Eurelings M; Lokhorst H; Franssen H; Fijnheer R; Wokke JH; Notermans NC
Neurology; 2006 Dec; 67(11):2076-9. PubMed ID: 17159126
[TBL] [Abstract][Full Text] [Related]
12. IgM MGUS associated with anti-MAG neuropathy: a single institution experience.
Talamo G; Mir MA; Pandey MK; Sivik JK; Raheja D
Ann Hematol; 2015 Jun; 94(6):1011-6. PubMed ID: 25572169
[TBL] [Abstract][Full Text] [Related]
13. Delayed appearance of anti-myelin-associated glycoprotein antibodies in a patient with chronic demyelinating polyneuropathy.
Valldeoriola F; Graus F; Steck AJ; Muñoz E; de la Fuente M; Gallart T; Ribalta T; Bombí JA; Tolosa E
Ann Neurol; 1993 Sep; 34(3):394-6. PubMed ID: 7689821
[TBL] [Abstract][Full Text] [Related]
14. Multifocal motor neuropathy with high titers of anti-MAG antibodies.
Bridel C; Horvath J; Kurian M; Truffert A; Steck A; Lalive PH
J Peripher Nerv Syst; 2014 Jun; 19(2):180-2. PubMed ID: 24863375
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies.
Magy L; Kaboré R; Mathis S; Lebeau P; Ghorab K; Caudie C; Vallat JM
J Immunol Res; 2015; 2015():450391. PubMed ID: 26065001
[TBL] [Abstract][Full Text] [Related]
16. Activation of the lectin pathway of complement in pig-to-human xenotransplantation models.
Bongoni AK; Kiermeir D; Jenni H; Wünsch A; Bähr A; Ayares D; Seebach JD; Wolf E; Klymiuk N; Constantinescu MA; Vögelin E; Rieben R
Transplantation; 2013 Nov; 96(9):791-9. PubMed ID: 23958924
[TBL] [Abstract][Full Text] [Related]
17. Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy.
Monaco S; Bonetti B; Ferrari S; Moretto G; Nardelli E; Tedesco F; Mollnes TE; Nobile-Orazio E; Manfredini E; Bonazzi L
N Engl J Med; 1990 Mar; 322(10):649-52. PubMed ID: 1689461
[TBL] [Abstract][Full Text] [Related]
18. Mannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo.
McMullen ME; Hart ML; Walsh MC; Buras J; Takahashi K; Stahl GL
Immunobiology; 2006; 211(10):759-66. PubMed ID: 17113913
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system involvement in patients with monoclonal gammopathy and polyneuropathy.
Lehmann HC; Hoffmann FR; Meyer Zu Hörste G; Hartung HP; Kieseier BC
Eur J Neurol; 2010 Aug; 17(8):1075-81. PubMed ID: 20236302
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic aberrations in neuropathy associated with IgM monoclonal gammopathy.
Eurelings M; Lokhorst HM; Notermans NC; Krijtenburg PJ; Kessel Bv; Eleveld MJ; Bloem A; Wokke JH; Poot M; Buijs A
J Neurol Sci; 2007 Sep; 260(1-2):124-31. PubMed ID: 17543994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
